Beyond ambiguous genitalia: Comprehensive diagnosis and management of congenital adrenal hyperplasia
PDF (Español (España))
html (Español (España))

Keywords

Neonatal Screening
Congenital Adrenal Hyperplasia
Steroid 21-Hydroxylase
Disorders of Sex Development
Gonadal Dysgenesis
46XX
17-alpha-Hydroxyprogesterone

How to Cite

Del Gordo Caballero, D., & Sposito, S. (2025). Beyond ambiguous genitalia: Comprehensive diagnosis and management of congenital adrenal hyperplasia. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 12(1). https://doi.org/10.53853/encr.12.1.919

Abstract

Introduction: Congenital Adrenal Hyperplasia encompasses a spectrum of enzyme anomalies of autosomal recessive inheritance where an enzyme necessary for synthesizing cortisol and aldosterone is absent or deficient. 21-hydroxylase deficiency is the most common cause, and its most severe presentation is the classic virilizing and salt-wasting form.

Purpose: This paper aims to present and discuss a classic case of congenital adrenal hyperplasia and expose the importance of its early detection to avoid the fatal consequences of not receiving prompt treatment.

Case presentation: Neonate with sex chromosome XX, with 21 hydroxylase deficiency in its classic form. The suspicion was raised through the discovery of male external genitalia, electrolyte alterations and karyotype. The diagnosis was confirmed with the measurement of androstenedione and 17 alpha-hydroxyprogesterone. Treatment was based on the correction of hyperkalemia and the use of glucocorticoids and mineralocorticoids.

Discussion and conclusion: Neonatal screening should be performed routinely. Early diagnosis is essential to avoid a potentially fatal adrenal crisis. The fundamental pillar of treatment is a hormonal replacement of glucocorticoids and mineralocorticoids, and long-term follow-up should also aim to avoid adrenal crises.

Congenital adrenal hyperplasia is a pathology that affects infant morbidity and mortality due to the clinical implications that result from an adrenal crisis. It is imperative that neonatal screening be implemented in Colombia to achieve prompt diagnosis and targeted treatment from an early age.

https://doi.org/10.53853/encr.12.1.919
PDF (Español (España))
html (Español (España))

References

Feldman Witchel S. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2017;30(5):520-34. https://doi.org/10.1016/j.jpag.2017.04.001

Latorre S, Garzón C, Manosalva G, Merchán S, Jacomussi L, Maldonado S. Hiperplasia adrenal congénita por déficit de 21 hidroxilasa: un reto diagnóstico y terapéutico. Repert Med Cir. 2016.;25(2):79-88. https://doi.org/10.1016/j.reper.2016.05.001

Lambert SM, Vilain EJ, Kolon TF. A practical approach to ambiguous genitalia in the newborn period. Urol Clin North Am. 2010;37(2):195-205. https://doi.org/10.1016/j.ucl.2010.03.014

Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, et al. Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr Rev. 2022;43(1):91-159. https://doi.org/10.1210/endrev/bnab016

Ponce CF, Campos E, Gómez Inestroza AM. Hiperplasia suprarrenal congénita. Reporte de caso. Act Ped Hond. 2015;4(2):313-7. https://doi.org/10.5377/pediatrica.v4i2.2227

El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390(10108):2194-210. https://doi.org/10.1016/S0140-6736(17)31431-9

Abarca-Acuña B, Delgado-Valencia E, Atamari-Anahui N, Zea-Núñez C. Ambigüedad sexual por hiperplasia suprarrenal congénita perdedora de sal por deficiencia de 21-hidroxilasa: informe de un caso. Rev Corpus Méd Hosp Nac Alamnzor Aguinaga Asenjo. 2015;8(1):25-7.

Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95(9):4133-60. https://doi.org/10.1210/jc.2009-2631

Congreso de la República. Ley número 1980, del 29 de julio de 2019. “Por medio de la cual se crea el programa de Tamizaje Neonatal en Colombia” [internet]. Diario oficial 51.026; 2019 [citado 2023, sept. 29]. https://www.minsalud.gov.co/Normatividad_Nuevo/Ley%201980%20de%202019.pdf

Sturm RM, Durbin-Johnson B, Kurzrock EA. Congenital adrenal hyperplasia: current surgical management at academic medical centers in the United States. J Urol. 2015;193(5S):1796-801. https://doi.org/10.1016/j.juro.2014.11.008

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.